41 results about "Mononucleosis" patented technology

Isolation plating medium of a first color for the identification of Listeria sp. and Listeria monocytogenes and Listeria ivanovii containing a first chromogenic substrate that responds to phosphatidylinositol-specific phospholipase C enzymes to release precipitate of a second color into the medium and a second chromogenic substrate that responds to beta-glucosidase enzymes to release precipitate of a third color into the medium, and said first, second and third colors contrasting with each other.

The invention discloses recombinant escherichia coli, a method for preparing phospholipase C and application. The recombinant escherichia coli BL21(DE-3)-pET-28a-L.m-phospholipase C (PLC) of which the target gene is from listeria monocyogenes (L.monocytogenes) is utilized as a fermentation strain to carry out liquid fermentation, so as to prepare phospholipase C. The method disclosed by the invention is simple in enzyme production process, short in production cycle and low in cost. A glycerophosphate bond on glyceryl phosphatide C3 can be specifically hydrolyzed to produce diglyceride (DAG) by using recombinant phospholipase C; plant crude oil (soybean oil, colleseed oil, rice bran oil and the like) is degummed by phospholipase C.

The invention discloses a mutation breeding method of lactobacillus plantarum and application of a strain of the lactobacillus plantarum. The collection number of the lactobacillus plantarum in China general microbiological culture collection center is CGMCC No 5297. The lactobacillus plantarum can generate bacteriocin which has a better inhibiting effect on multiple gram-positive bacteria and especially has great a high inhibiting effect on listeria monocytogenes, and the bacteriocin has the advantages of better heat stability, acid stability and the like and can be applied as a food additive and a feed preservative agent which have wide application prospect.

The invention discloses a tobacco high-effective foliar fertilizer as well as a preparation method and an application thereof. The foliar fertilizer contains 10-20 parts of stenotrophomonas maltophilia bacteria, 8-12 parts of providencia stuartii bacteria, 8-12 parts of mononucleosis bacteria, 8-12 parts of chitosan, 8-12 parts of amino acid, 8-12 parts of algin, 10-20 parts of micro-fertilizer and 20-40 parts of water. The foliar fertilizer is applied to increase of tobacco production, improvement of tobacco quality, induced enhancement of tobacco disease resistance, promotion of growth of tobacco plants and the like, and has the advantages of being remarkable in effect, green, pollution-free and high in fertilizer utilization rate, controlling disease, increasing yield and quality, beinglow in cost and easy to popularize and the like.

The invention discloses a traditional Chinese medicine preparation for treating pediatric infectious mononucleosis. The traditional Chinese medicine preparation is prepared from the following medicinal raw materials by weight: 20-30g of fresh phragmites, 10-20g of herba lophatheri, 10-20g of herba menthae, 10-20g of radix isatidis, 10-20g of folium isatidis, 10-20g of cortex lycii, 10-20g of adenophora, 10-20g of violet, 8-12g of raw licorice, 8-15g of spica prunellae, 8-12g of carapax trionycis, 8-12g of radix curcumae, 8-12g of radix cynanchi atrati, 8-12g of rhizoma anemarrhenae, 8-12g of concha arcae and 8-12g of semen armeniacae amarum. The medicinal raw materials are well matched to achieve the efficacies of nourishing yin, moistening lung, boosting qi, engendering liquid, clearing away heat and toxic materials, preventing phlegm from forming, stopping coughing, and the like, the purpose of preventing virus infection can be achieved in a way of influencing an immune system and the like, and the traditional Chinese medicine preparation is remarkable in treatment effect on pediatric infectious mononucleosis, has no side effect and is high in cure rate, thus being worthy of clinical popularization and application.

The present invention relates to compositions comprising a lipophilic local anaesthetic, preferably bupivacaine or a pharmaceutically active salt thereof, which are formulated for local administration to the mouth or throat of a subject. The compositions are useful in the treatment or alleviation of pain, burning or xerostomia of the oral cavity, pharynx, oral mucosa and pharyngeal mucosa or for use in providing local anesthesia of the oral cavity, pharynx, oral mucosa and pharyngeal mucosa. In particular in the treatment of pain, burning or xerostomia, which is caused by a disease such as oral mucositis, Burning Mouth Syndrome, Sjogren's syndrome, xerostomia, periodontitis, toothache, tonsillectomy, throat infection or mononucleosis, canker sores and aphthous stomatitis.

The invention provides an EB virus BFRF3-BZLF1 fusion protein, a gene, a vector containing the BZLF1 fusion protein, a host cell, a test strip, a production method and application thereof. The EB virus BFRF3-BZLF1 fusion protein is obtained by connecting the EB virus BFRF3 protein or an EB virus BFRF3 protein fragment with an EB virus BZLF1 protein or EB virus BZLF1 protein fragment through a connecting peptide, and preferably, the EB virus BFRF3-BZLF1 fusion protein has an amino acid sequence shown in SEQ ID NO:1. The EB virus BFRF3-BZLF1 fusion protein can be used as a target antigen for detecting an EB virus, provides a basis for screening and early diagnosing nasopharyngeal carcinoma, infectious mononucleosis and Burkitt lymphoma, and has the advantages of simplicity, rapidness, sensitivity and specificity.

The invention discloses a non-chemical pesticide for preventing and treating acarids. The non-chemical pesticide is characterized by comprising the following components in parts by weight: 1-3 parts of mononucleosis powder, 0.5-1.0 part of bacillus subtilis powder, 6-10 parts of gelsmium elegans powder, 1-6 parts of antiaris toxicaria powder, 30-45 parts of luffa stem, 21-35 parts of folium artemisiae argyi, 20-31 parts of houttuynia cordata, 5-18 parts of common andrographis herb, 1-5 parts of an emulsifier, 1-10 parts of turpentine, 8-13 parts of croton, 3-6 parts of radix polygonati officinalis, 2-4 parts of rhizoma nardostachyos, 1-3 parts of liquorice and 3-9 parts of euphorbia kansui. The non-chemical pesticide has the characteristics of both biological pesticides and plant pesticides, if a synergist is added, the pesticide effect is in geometrical progression relationship with the components, the experiment data show that the pesticide effect of the non-chemical pesticide is 10-20 times of that of a single component, and the non-chemical pesticide is low in toxicity for human beings and livestock.

Anti-Epstein Barr Virus (EBV) antibodies and vaccines are described herein. The antibodies and vaccines can be used to treat and/or reduce the risk of EBV infection and to treat and/or reduce the risk of complications associated with EBV infection, such as infectious mononucleosis, lymphoproliferative disorders, carcinomas, and smooth muscle tumors.

The invention discloses an application of an adenosine derivative shown as a formula (I) (as shown in the Description) in preparing medicines for preventing or/and treating hyperlipidaemia accompanied mononucleosis, and an application of the adenosine derivative in preparing medicines for preventing or/and treating atherosclerosis, wherein the prevention or/and treatment of the atherosclerosis is/are to prevent or/and treat atherosclerosis-associated inflammatory mononucleosis. Specifically, triacetyl-3-hydroxyphenyl adenosine, in vivo, can obviously reduce the number of monocytes of inflammatory monocytes Ly6Chi in circulating blood of apoE-/- mice and golden hamsters which are fed with high-lipid diet, so that an anti-inflammatory effect can be achieved.

The invention relates to a traditional Chinese medicine composition for treating children infectious mononucleosis. The traditional Chinese medicine composition comprises carapax trionycis, raw oyster shells, herba schizonepetae, isatidis radix, mint, folium isatidis, radix glycyrrhizae, herba violae, lycium bark, scrophulariae, shikonin, olibanum, gypsum rubrum, concha arcae, radix scutellaria and indigo naturalis, and has the effects of clearing away heat and toxic materials. After the traditional Chinese medicine composition is taken, the medicine treats both symptoms and root causes from the whole human body, has the functions of nourishing the liver and kidney, calming the liver, recovering lymph glands and expelling toxin and achieving detoxication, eliminates EB viruses fundamentally, promotes blood circulation and the respiratory cycle, and enables the blood circulation system and the respiratory system to recover self-adjusting functions; completely relieves the symptoms of strength lack, fever, myalgia, lymphadenopathy, liver gland swelling and the like, improves microcirculation, adjusts endocrine function disorder, and finally achieves the purpose of curing the children infectious mononucleosis.

The invention discloses a traditional Chinese medicine for treating infectious mononucleosis. The traditional Chinese medicine is prepared by the following medicinal materials: radix bupleuri, pinellia ternate, scutellaria baicalensis, ginseng, cortex moutan, honeysuckle, milfoil, rhizoma phragmitis, fructus forsythia, bamboo leaves, mentha haplocalyx, semen coicis, honeysuckle stem, evodia lepta, radix tetrastigme, herba eupatorii, agastache rugosus, radix isatidis, folium isatidis, radix polygonati officinalis, radix scrophulariae, gypsum, fructus gardeniae, dandelion, indian strawberry, ixeris chinensis, epipremum pinnatum, sarel spleenwort herb, royal paulowinia flower, trollflower, burdock, platycodon grandiflorum, almond, fritillaria cirrhosa, spica prunellae, stiff silkworm, sargassum, kelp, red peony root, peach kernel, artemisia apiacea, turtle shell, adenophora stricta, bupleurum falcatum, radix ophiopogonis, rhizoma picrorhizae, cortex lycii radicis, puerarin, radix trichosanthis, caulis bambusae in taeniam, radix clematidis and radix stemonae. Clinical experiments prove that the traditional Chinese medicine is capable of safely and effectively treating the infectious mononucleosis.

The present invention refers to strains of lactic bacteria and/or bifidobacteria having activity of inhibiting/reducing the growth of different biotypes of E. coli, including E. coli O157:7 and different biotypes of clostridia, including Clostridium difficile, Listeria monocytogenes, Enterococcus sp. and Klebsiella sp. Furthermore, the present invention refers to a pharmaceutical or dietary composition or a supplement or a medical device comprising at least one of the said strains of bacteria, optionally in combination with acetylcysteine and/or microencapsulated gastroprotected lysozyme and/or acetylcysteine with microencapsulated gastroprotected lysozyme.

The invention relates to the field of gene engineering, and aims to provide a construction method and application of novel attenuated listeria monocytogenes based on amino acid modification. The attenuated monocytosis listeria is obtained by taking a listeria monocytosis wild strain as a background and knocking out 251-255th amino acids in an hly gene. The invention provides an attenuated strain containing the attenuated listeria monocytogenes, and the attenuated strain is preserved in China General Microbiological Culture Collection Center (CGMCC). The attenuated strain of the listeria monocytogenes can be used as an exogenous antigen delivery live vector for immunotherapy or immunologic adjuvants of diseases such as tumors and the like. Due to the fact that knockout modification is carried out on the genome of the listeria monocytogenes, biomarkers such as resistant plasmids are not contained, biological safety is met, and in-vitro growth of the listeria monocytogenes is not affected.

The invention relates to a healthy breeding method of crayfishes. The method particularly comprises the following steps of (1) breeding pond cleaning; (2) breeding soil exposure; (3) crayfish disinfection; (4) stocking; (5) fungus resistance; (6) oxygenation and water change; (7) mononucleosis resistance; the bottom of a breeding pond is thoroughly cleaned and disinfected to ensure that no other worm eggs survive; a mixture of tobacco leaf water, tea cake and sulfamerazine is regularly sprayed for disinfection and anti-inflammation to prevent inflammations and fungi from occurring in crayfishbodies.

The invention discloses a Chinese medicinal preparation for treating infantile infectious mononucleosis, and the Chinese medicinal composition is prepared from the following raw materials by weight: 20-30g of fresh reed rhizome, 10-20g of weeping forsythia, 10-20g of lophantherum gracile, 10-20g of isatis root, 10-20g of mint, 10-20g of folium isatidis, 10-20g of licorice, 10-20g of radix scutellariae, 10-20g of cortex lycii radicis, 8-15g of root of straight ladybell, 8-12g of blackend swallowwort root, 8-12g of anemarrhenae, 8-12g of self-heal, 8-12g of ark shell, 8-12g of dandelion and 8-12g of curcuma. The medicaments are well compatible; the formula is neutral and mild; the Chinese medicinal preparation has the effects of nourishing yin and lung, benefiting qi for promoting production of fluid, clearing heat, detoxifying and eliminating dampness and phlegm, fulfills the purpose of resisting virus infection by influencing the immune system, has a significant effect of treating infantile infectious mononucleosis, does not have side effect and has high cure rate, so that the Chinese medicinal preparation is worthy of clinical popularization and application.